Back
Netlist, Inc. 10K Form
Sell
29
NLST
Netlist, Inc.
Last Price:
$0.69
Seasonality Move:
48.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-06 | 10Q | NLST/Netlist, Inc. Quarterly |
| 2023-11-09 | 10Q | NLST/Netlist, Inc. Quarterly |
| 2023-08-08 | 10Q | NLST/Netlist, Inc. Quarterly |
| 2023-05-10 | 10Q | NLST/Netlist, Inc. Quarterly |
| 2022-11-02 | 10Q | NLST/Netlist, Inc. Quarterly |
| 2022-08-04 | 10Q | NLST/Netlist, Inc. Quarterly |
Receive NLST News And Ratings
See the #1 stock for the next 7 days that we like better than NLST
NLST Financial Statistics
Sales & Book Value
| Annual Sales: | $147.1M |
|---|---|
| Cash Flow: | $-10.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.05 |
| Price / Book: | 33.7 |
Profitability
| EPS (TTM): | -0.12790 |
|---|---|
| Net Income (TTM): | $-35.3M |
| Gross Margin: | $2.9M |
| Return on Equity: | -441.41% |
| Return on Assets: | -83.76% |
Netlist, Inc. Earnings Forecast
Key Netlist, Inc. Financial Ratios
-
The Gross Profit Margin over the past 23 years for NLST is 1.96%.
-
The Selling, General & Administrative Expenses for NLST have been equal to 8.22% of Gross Profit Margin.
-
The Research & Development expenses have been 5.48% of Revenue.
-
The Net Earning history of NLST is -36.62% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 14 years.
Netlist, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Electronic Equipment, Instruments & Components |
| Sector: | Information Technology |
| Current Symbol: | NLST |
| CUSIP: | 64118P |
| Website: | netlist.com |
Debt
| Debt-to-Equity Ratio: | -0.32 |
|---|---|
| Current Ratio: | 0.79 |
| Quick Ratio: | 0.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NLST Technical Analysis vs Fundamental Analysis
Sell
29
Netlist, Inc. (NLST)
is a Sell
Is Netlist, Inc. a Buy or a Sell?
-
Netlist, Inc. stock is rated a SellThe current Netlist, Inc. [NLST] share price is $0.72. The Score for NLST is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.